Abstract
Patients with primary gout and excessive uric acid excretion fed a test dose of 15N-glycine incorporate increased quantities of 15N into urinary urate [1–4]. Although enrichment of all 4 nitrogen atoms of uric acid is excessive [4,5] that of N−(3+9) is disproportionately great, especially in flamboyant overexcretors of uric acid [5]. Since N−3 and N−9 of uric acid are derived from the amide-N of glutamine [6,7], Gutman and Yu [5,8] proposed a defect in glutamine metabolism in primary gout. Since urinary ammonium, which arises principally from glutamine [9,10], is reduced in many gouty subjects [11,12], they further postulated a reduction of glutaminase activity [5,8]. The hyperglutamatemia of gout has now suggested a defect of glutamate metabolism, with diversion of glutamic acid toward glutamine and purine biosynthesis [13,14].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benedict, J. D., T.-F. Yu, E. J. Bien, A. B. Gutman, and DeW. Stetten, Jr. 1953. A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J. Clin. Invest. 32:775.
Gutman, A. B., T.-F. Yu, H. Black, R. S. Yalow, and S. A. Berson. 1958. Incorporation of glycine 1-C14 and glycine-N15 into uric acid in normal and gouty subjects. Amer. J. Med. 25:917.
Seegmiller, J. E., A. I. Grayzel, L. Laster, and L. Liddle. 1961. Uric acid production in gout. J. Clin. Invest. 40:1304.
Gutman, A. B., T.-F. Yu, M. Adler, and N. B. Javitt. 1962. Intramolecular distribution of uric acid-N15 after administration of glycine-N15 and ammonium N15 chloride to gouty and nongouty subjects. J. Clin. Invest. 41:623.
Gutman, A. B., and T.-F. Yu. 1963. An abnormality of glutamine metabolism in primary gout. Amer. J. Med. 35:820.
Sonne, J. C, I. Lin, and J. M. Buchanan. 1956. Biosynthesis of the purines. IX. Precursors of the nitrogen atoms of the purine ring. J. Biol. Chem. 220:369.
Levenberg, B., S. C. Hartman, and J. M. Buchanan. 1956. Biosynthesis of the purines. X. Further studies in vitroon the metabolic origin of nitrogen atoms 1 and 3 of the purine ring. J. Biol. Chem. 220:379.
Gutman, A. B., and T.-F. Yu. 1963. On the nature of the inborn metabolic error (s) of primary gout. Trans. Assoc. Amer. Physicians 76:141.
Pitts, R. F., L. A. Pilkington, and J. C. M. DeHaas. 1965. N15 tracer studies on the origin of urinary ammonia in the acidotic dog, with notes on the enzymatic synthesis of labeled glutamic acid and glutamine. J. Clin. Invest. 44:731.
Stone, W. J., S. Balagura, and R. F. Pitts. 1967. Diffusion equilibrium for ammonia in the kidney of the acidotic dog. J. Clin. Invest. 46:1603.
Gutman, A. B., and T.-F. Yu. 1965. Urinary ammonium excretion in primary gout. J. Clin. Invest. 44:1474.
Sperling, O., M. Frank, and A. de Vries. 1966. L’excretion d’ammoniac au cours de la goutte. Rev. Franc. Etud. Clin. Biol. 11:401.
Yu, T.-F., M. Adler, E. Bobrow, and A. B. Gutman. 1969. Plasma and urinary amino acids in primary gout, with special reference to glutamine. J. Clin. Invest. 48:885.
Pagliara, A. S., and A. D. Goodman. 1969. Elevation of plasma glutamate in gout, its possible role in the pathogenesis of hyperuricemia. New Eng. J. Med. 281:767.
Kelley, W. N., F. M. Rosenbloom, J. E. Seegmiller, and R. R. Howell. 1968. Excessive production of uric acid in type I glycogen storage disease. J. Pediat. 72:488.
Kelley, W. N., M. L. Greene, F. M. Rosenbloom, J. F. Henderson, and J. E. Seegmiller. 1969. Hypoxanthine-guanine phosphoribosyl-transferase deficiency in gout. Ann. Intern. Med. 70:155.
Emmerson, B. T., and J. B. Wyngaarden. 1969. Purine metabolism in heterozygous carriers of hypoxanthine guanine phosphoribosyltransferase deficiency. Science. 166:1533.
Sperling, O., M. Frank, R. Ophir, U. A. Liberman, A. Adam, and A. de Vries. 1970. Partial deficiency of hypoxanthineguanine phosphoribosyltransferase associated with gout and uric acid lithiasis. Rev. Europ. Etud. Clin. Biol. 15:942.
Sperling, O., P. Boer, S. Persky-Brosh, E. Kanarek, and A. de Vries. 1972. Altered kinetic property of erythrocyte phosphoribosylpyrophosphate synthetase in excessive purine production. Europ. J. Clin. Biol. Res. 17:703.
Sperling, O., S. Persky-Brosh, P. Boer, and A. de Vries. 1973. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties. Biochem. Med. In press.
Becker, II, A., L. J. Meyer, A. W. Wood, and J. E. Seegmiller. 1973. Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity. Science 179:1123.
Schoenheimer, R., and S. Ratner. 1939. Studies in protein metabolism. III. Synthesis of amino acids containing isotopic nitrogen. J. Biol. Chem. 127:301.
Praetorius, E. 1949. An enzymatic method for the determination of uric acid by ultraviolet spectrophotometry. Scand. J. Clin. Lab. Invest. 1:222.
Shemin, D., and D. Rittenberg. 1947. On the utilization of glycine for uric acid synthesis in man. J. Biol. Chem. 167:875.
Brandenberger, H. 1954. The oxidation of uric acid to oxonic acid (allantoxanic acid) and its application in tracer studies of uric acid biosynthesis. Biochim. Biophys. Acta. 15:108.
Sonne, J. C, I. Lin, and J. M. Buchanan. 1956. Biosynthesis of the purines. IX. Precursors of the nitrogen atoms of the purine ring. J. Biol. Chem. 220:369.
Quick, A. J. 1940. Clinical application of hippuric acid and prothrombin tests. Amer. J. Clin. Path. 10:222.
Howell, R. R., M. Speas, and J. B. Wyngaarden. 1961. A quantitative study of recycling of isotope from glycine-1-C14, α-N-15 into various subunits of the uric acid molecule in a normal subject. J. Clin. Invest. 40:2076.
Stein, W. H. 1953. A Chromatographic investigation of the amino acid constituents of normal urine. J. Biol. Chem. 201:45.
Hirs, C. H., S. Moore, and W. H. Stein. 1954. The chromatography of amino acids on ion exchange resins. Use of volatile acids for elution. J. Amer. Chem. Soc. 76:6063.
Prescott, B. A., and H. Waelsch. 1947. Free and combined glutamic acid in human blood plasma and serum. J. Biol. Chem. 167:855.
Rittenberg, D. 1946. Preparation of gas samples for mass spectrographic isotope analysis. In Preparation and Measurement of Isotopic Tracers. D. W. Wilson, A. O. C. Nier, and S. P. Reimann, editors. Edwards, Ann Arbor, 31.
Gutman, A. B., and T.-F. Yu. 1957. Renal function in gout with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Amer. J. Med. 23:600.
Lesch, M., and W. L. Nyhan. 1964. A familial disorder of uric acid metabolism and central nervous function. Amer. J. Med. 36:561.
Sperling, O., G. Eilam, S. Persky-Brosh, and A. de Vries. 1972. Accelerated erythrocyte 5-phosphoribosyl-l-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout. Biochem. Med. 6:310.
Henderson, J. F., F. M. Rosenbloom, W. N. Kelley, and J. E. Seegmiller. 1968. Variations in purine metabolism of cultured skin fibroblasts from patients with gout. J. Clin. Invest. 47:1511.
Seegmiller, J. E., J. R. Klinenberg, J. Miller, and R. W. E. Watts. 1968. Suppression of glycine-N-15 incorporation into urinary uric acid by adenine-8-C13 in normal and gouty subjects. J. Clin. Invest. 47:1193.
Kelley, W. N., F. M. Rosenbloom, and J. E. Seegmiller. 1967. The effect of azathioprine (Imuran) on purine synthesis in clinical disorders of purine metabolism. J. Clin. Invest. 46:1518.
Wyngaarden, J. B. 1966. Gout. In The Metabolic Basis of Inherited Disease, 2nd ed. J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, editors. New York, McGraw-Hill, p. 667.
Draper, N. R., and H. Smith. 1966. Applied Regression Analysis. New York, John Wiley, Chp. 10.
Sherwin, C. P., M. Wolf, and W. Wolf. 1919. The maximum production of glutamine by the human body as measured by the output of phenylacetylglutamine. J. Biol. Chem. 37:113.
Moldave, K., and A. Meister. 1957. Synthesis of phenylacetylglutamine by human tissue. J. Biol. Chem. 229:463.
Zilversmit, D. B., C. Entenman, and M. C. Fishier. 1943. On the calculation of “turnover time” and “turnover rate” from experiments involving the use of labeling agents. J. Gen. Physiol. 26:325.
Starmer, C. F., O. Sperling, and J. B. Wyngaarden. A kinetic model for uric acid labeling in primary gout. In preparation.
Wu, H., and C. W. Bishop. 1959. Pattern of N15-excretion in man following administration of N15-labeled glycine. J. Appl. Physiol. 14:1.
Wyngaarden, J. B. 1972. Glutamine phosphoribosylpyrophosphate amidotransferase. In Current Topics in Cellular Regulation. B. Horecker and E. R. Stadtman, editors. New York, Academic Press, Vol. V, p. 135.
Holmes, E. W., J. A. McDonald, J. M. McCord, J. B. Wyngaarden, and W. N. Kelley. 1973. Human glutamine phosphoribosylpyrophosphate amidotransferase: Kinetic and regulatory properties. J. Biol. Chem. 248:144.
Holmes, E. W., J. B. Wyngaarden and W. N. Kelley. 1973. Human glutamine phosphoribosylpyrophosphate amidotransferase: Two molecular forms interconvertible by purine ribonucleotides and phosphoribosylpyrophosphate. J. Biol. Chem. (In press.).
Greene, M. L., and J. E. Seegmiller. 1969. Elevated erythrocyte phosphoribosylpyrophosphate in X-linked uric aciduria: Importance of PRPP concentration in the regulation of human purine biosynthesis. J. Clin. Invest. 48:32a.
Fox, I., and W. N. Kelley. 1971. Phosphoribosylpyrophosphate in man: Biochemical and clinical significance. Ann. Intern. Med. 74:424.
Fox, I. H., J. B. Wyngaarden, and W. N. Kelley. 1970. Depletion of erythrocyte phosphoribosylpyrophosphate in man, a newly observed effect of allopurinol. New Eng. J. Med. 283:1177.
Henderson, J. F., and M. K. Y. Khoo. 1965. Synthesis of 5-phosphoribosyl-1-pyrophosphate from glucose in Ehrlich ascites tumor cells in vitro. J. Biol. Chem. 240:2349.
Kelley, W. N., I. H. Fox, and J. B. Wyngaarden. 1970. Regulation of purine biosynthesis in cultured human cells. I. Effects of orotic acid. Biochim. Biophys. Acta. 215:512.
Hershko, A., C. Hershko, and J. Mager. 1968. Increased formation of 5-phosphoribosyl-l-pyrophosphate in red blood cells of some gouty patients. Israel Med. J. 4:939.
Sperling, O., R. Ophir, and A. de Vries. 1971. Purine base incorporation into erythrocyte nucleotides and erythrocyte phosphoribosyltransferase activity in primary gout. Rev. Europ. Etudes Clin. et Biol. 16:147.
Jones, O. W., Jr., D. M. Ashton, and J. B. Wyngaarden. 1962. Accelerated turnover of phosphoribosylpyrophosphate, a purine nucleotide precursor, in certain gouty subjects. J. Clin. Invest. 41:1805.
Segal, S., and J. B. Wyngaarden. 1955. Plasma glutamine and oxypurine content in patients with gout. Proc. Soc. Exp. Biol. Med. 88:342.
Wood, A. W. and Seegmiller, J. E. 1973. Properties of 5-phosphoribosyl-1-pyrophosphate amidotransferase from human lymphoblasts. J. Biol. Chem. 248:138.
Raivio, K. O., and J. E. Seegmiller. 1971. Role of glutamine in purine synthesis and interconversion. Clin. Res. 19:161.
Williamson, D. H., O. Lopes-Vieira, and B. Walker. 1967. Concentrations of free glucogenic amino acids in livers of rats subjected to various metabolic stresses. Biochem. J. 104:497.
Kennan, A. L. 1962. Glutamine synthesis in rats with diabetic acidosis. Endocrinology. 71:203.
Bergmeyer, H. U. 1970. Methoden der enzymatischen Analyse, Verlag-Chemie. Weinheim/ Bergstrasse. Book II. p. 2206.
Caskey, C. T., D. M. Ashton, and J. B. Wyngaarden. 1964. The enzymology of feedback inhibition of glutamine phosphoribosylpyrophosphate amidotransferase by purine ribonucleotides. J. Biol. Chem. 239:2570.
Pollak, V. E., and H. Mattenheimer. 1965. Glutaminase activity in the kidney in gout. J. Lab. Clin. Med. 66:564.
Pitts, R. F. 1964. Renal production and excretion of ammonia. Amer. J. Med. 36:720.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sperling, O., Wyngaarden, J.B., Starmer, C.F. (1974). The Kinetics of Intramolecular Distribution of 15N in Uric Acid Following Administration of 15N-Glycine: Preferential Labeling of N−(3+9) of Uric Acid in Primary Gout and a Reappraisal of the “Glutamine Hypothesis”. In: Sperling, O., De Vries, A., Wyngaarden, J.B. (eds) Purine Metabolism in Man. Advances in Experimental Medicine and Biology, vol 41. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-1433-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1433-3_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-1435-7
Online ISBN: 978-1-4757-1433-3
eBook Packages: Springer Book Archive